CASI Pharmaceuticals, Inc. (CASI) is still in bottoming mode. The technical indicators are looking better now for the stock. The MACD is starting to rise, confirming a bullish divergence has taken form and the Stochastic also has a bullish crossover. It might attempt to breakout above the $1.25 level on Monday and if it succeeds we should expect a strong move to the upside. It has the potential to make another big run next week, so keep a close eye on CASI and don’t miss the trade. The price target of the two Wall Street analysts that rated the stock since the last quarterly report is $3.9